Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in BCAX — Bicara Therapeutics Inc.

CIK 1446194 BALA CYNWYD, PA

Position in BCAX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$217,676 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
6 quarters on record

Common Shares in BCAX Over Time

Shares Held

Position Value (USD)

Derivatives in BCAX

reported options exposure · as of Jun 30, 2026
CallValue
$388,939
CallShares
13,100
PutValue
$843,196
PutShares
28,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in BCAX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $843,196 28,400
2026-06-30 $388,939 13,100
2026-03-31 $1,300,806 65,400
2026-03-31 $217,676 10,944
2026-03-31 $839,358 42,200
2025-12-31 $1,023,264 60,800
2025-12-31 $516,563 30,693
2025-09-30 $205,270 13,000
2025-06-30 $401,773 43,248
2025-03-31 $324,473 24,902